找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Difficult Acute Cholecystitis; Treatment and Techni Isidoro Di Carlo Book 2021 Springer Nature Switzerland AG 2021 Acute cholecystitis.chol

[復(fù)制鏈接]
樓主: palliative
11#
發(fā)表于 2025-3-23 13:16:46 | 只看該作者
12#
發(fā)表于 2025-3-23 17:50:55 | 只看該作者
Pathophysiology and Diagnosis of Acute Acalculous Cholecystitis, should be screened in all critically ill or injured patients with sepsis, especially in cases where the cause of sepsis is not clear, in case of hypoperfusion, onset of jaundice, and/or postoperative setting.
13#
發(fā)表于 2025-3-23 20:36:13 | 只看該作者
Tokyo Guidelines and Their Limits,n numerous research studies of acute cholecystitis, there is still room for discussion about the flowchart for management. Here, we describe the outlines of TG18 and room for its improvement in the future.
14#
發(fā)表于 2025-3-24 01:56:57 | 只看該作者
Difficult Laparoscopic Cholecystectomy: Timing for Conversion,hlight the importance of conversion as wise approach in the difficult cholecystectomy case where the risks of continuing with the laparoscopic cholecystectomy clearly outweigh the morbidity that comes with conversion to open.
15#
發(fā)表于 2025-3-24 03:52:00 | 只看該作者
When Is It Safe to Continue Laparoscopically?,e surgical exposure, (5) consult for a second opinion, and (6) the adoption of alternative laparoscopic procedures (subtotal cholecystectomy, cholecystostomy) or conversion to laparotomy. A calm, reflective and shared responsibility attitude is essential for surgical decision-making for the development of a safety culture during cholecystectomy.
16#
發(fā)表于 2025-3-24 08:36:16 | 只看該作者
17#
發(fā)表于 2025-3-24 11:51:16 | 只看該作者
18#
發(fā)表于 2025-3-24 18:45:11 | 只看該作者
19#
發(fā)表于 2025-3-24 19:38:03 | 只看該作者
20#
發(fā)表于 2025-3-25 02:49:52 | 只看該作者
Verfahrensbeschreibung Tiefziehen,elderly population. The aim of this chapter is to combine and briefly summarize the WSES guidelines on ACC and to provide a quick and easy-to-use tool for physicians treating this challenging disease.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 19:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
双城市| 嫩江县| 罗定市| 静宁县| 峡江县| 济阳县| 宜昌市| 巴林左旗| 五指山市| 桃园市| 新邵县| 巴南区| 汉源县| 南城县| 新疆| 镇平县| 淮滨县| 怀来县| 巧家县| 新宁县| 海原县| 兖州市| 昔阳县| 仁寿县| 海城市| 达孜县| 济源市| 朝阳区| 乐山市| 汾西县| 晋江市| 田东县| 唐海县| 衡东县| 林芝县| 苏尼特右旗| 长武县| 阿巴嘎旗| 宁武县| 洪泽县| 柳州市|